Rockefeller Capital Management L.P. - ELEDON PHARMACEUTICALS INC ownership

ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 31 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rockefeller Capital Management L.P. ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$3
-99.9%
1,6660.0%0.00%
Q3 2022$4,0000.0%1,6660.0%0.00%
Q2 2022$4,000
-33.3%
1,6660.0%0.00%
Q1 2022$6,000
-14.3%
1,6660.0%0.00%
Q4 2021$7,000
-30.0%
1,6660.0%0.00%
Q3 2021$10,000
-23.1%
1,6660.0%0.00%
Q2 2021$13,000
-23.5%
1,6660.0%0.00%
Q1 2021$17,0001,6660.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CM Management, LLC 245,000$676,0000.76%
BVF INC/IL 2,326,710$6,422,0000.26%
Cormorant Asset Management, LP 1,223,500$3,377,0000.24%
Ikarian Capital, LLC 221,830$612,0000.12%
JMAC ENTERPRISES LLC 54,538$151,0000.04%
Woodline Partners LP 516,675$1,426,0000.02%
Eversept Partners, LP 67,743$186,9710.02%
INGALLS & SNYDER LLC 51,149$141,0000.01%
Point72 Asset Management, L.P. 375,000$1,035,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 22,050$61,0000.00%
View complete list of ELEDON PHARMACEUTICALS INC shareholders